Skip to main
SYK
SYK logo

Stryker (SYK) Stock Forecast & Price Target

Stryker (SYK) Analyst Ratings

Based on 15 analyst ratings
Buy
Strong Buy 40%
Buy 40%
Hold 20%
Sell 0%
Strong Sell 0%

Bulls say

Stryker's management has reiterated expectations for a significant increase in operating margin by approximately 100 basis points by 2025, indicating potential for continued profitability amidst challenges such as tariffs. The company has reported remarkable growth in its order book and demonstrated strong performance with record MAKO installations, underscoring healthy momentum in its orthopedic division. Additionally, Stryker's strategic focus on high-growth markets has led to an increase in its weighted average market growth rate, positioning the company for robust revenue and earnings per share growth in the coming years.

Bears say

Stryker's outlook is negatively impacted by several challenges, including disruptions from recent acquisitions, a deceleration in Mako utilization due to increased competition, and a weaker capital environment for hospitals. Organic revenue growth is anticipated to slow to 8% or less, compounded by potential earnings dilution from acquisitions and underwhelming new product launches, which may lead to below-consensus earnings projections. Furthermore, risks such as reduced market growth in orthopedics, challenges in capital spending, and integration difficulties from acquisitions contribute to a forecast of limited margin expansion and overall earnings growth.

Stryker (SYK) has been analyzed by 15 analysts, with a consensus rating of Buy. 40% of analysts recommend a Strong Buy, 40% recommend Buy, 20% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Stryker and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Stryker (SYK) Forecast

Analysts have given Stryker (SYK) a Buy based on their latest research and market trends.

According to 15 analysts, Stryker (SYK) has a Buy consensus rating as of Nov 25, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $435.33, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $435.33, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Stryker (SYK)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.